F.D.A. Approves GHB, a ‘Date Rape’ Drug, for Rare Sleeping Disorder


By BY VIRGINIA HUGHES from NYT Jazz Pharmaceuticals brought in more than $1.7 billion last year selling GHB to narcolepsy patients. With the new approval, sales could soar.Health https://ift.tt/3AG4mlt
via

Related Posts:

0 comments:

Post a Comment

Sample Text

Blog Archive

Powered by Blogger.

Social Widget